Nucleus Software Intrinsic Value
Nucleus Software (NUCLEUS) median intrinsic value is ₹433.85 from 9 valuation models (range ₹295–₹754), vs current price ₹775.45 — -44.1% downside (Trading Above Calculated Value), margin of safety -78.7%. Also explore Nucleus Software share price performance to track price trends across different timeframes.
NUCLEUS Valuation Methods Summary — DCF, Graham Number & P/E
Nucleus Software intrinsic value across 9 models vs current price ₹775.45 — upside/downside and value range per method. Browse NUCLEUS financial statements for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹629.76 | ₹503.81 - ₹755.71 | -18.8% | EPS: ₹52.48, Sector P/E: 12x |
| Book Value Method | asset | ₹348.85 | ₹313.97 - ₹383.74 | -55.0% | Book Value/Share: ₹348.85, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹295.38 | ₹265.84 - ₹324.92 | -61.9% | Revenue/Share: ₹369.23, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹433.85 | ₹390.47 - ₹477.24 | -44.1% | EBITDA: ₹188.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹583.76 | ₹467.01 - ₹700.51 | -24.7% | CF Growth: 7.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹335.87 | ₹302.28 - ₹369.46 | -56.7% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹432.44 | ₹389.20 - ₹475.68 | -44.2% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹753.85 | ₹678.47 - ₹829.24 | -2.8% | ROE: 15.4%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹641.81 | ₹577.63 - ₹705.99 | -17.2% | EPS: ₹52.48, BVPS: ₹348.85 |
NUCLEUS Intrinsic Value vs Market Price — All Valuation Models
Nucleus Software fair value range ₹295–₹754 vs current market price ₹775.45 across 9 valuation models. For current market price and key ratios, visit Nucleus Software stock price NSE.
NUCLEUS Intrinsic Value Analysis — Undervalued or Overvalued?
Nucleus Software median intrinsic value ₹433.85, current price ₹775.45 — Trading Above Calculated Value by 44.1%, margin of safety -78.7%.
What is the intrinsic value of NUCLEUS?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Nucleus Software (NUCLEUS) is ₹433.85 (median value). With the current market price of ₹775.45, this represents a -44.1% variance from our estimated fair value.
The valuation range spans from ₹295.38 to ₹753.85, indicating ₹295.38 - ₹753.85.
Is NUCLEUS undervalued or overvalued?
Based on our multi-method analysis, Nucleus Software (NUCLEUS) appears to be trading above calculated value by approximately 44.1%.
NUCLEUS Financial Health — Key Ratios vs Industry Benchmarks
Nucleus Software financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 7.75 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 15.4% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 14.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.76x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
NUCLEUS Cash Flow Quality — Operating & Free Cash Flow
Nucleus Software operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹151 Cr | ₹141 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹222 Cr | ₹124 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹50 Cr | ₹44 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹58 Cr | ₹58 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹115 Cr | ₹52 Cr | Positive Free Cash Flow | 7/10 |